Sharing sensitive data in life sciences: an overview of centralized and federated approaches.

FAIR principles GDPR biomedical data centralized model data sharing federated model

Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 06 02 2024
revised: 19 04 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: ppublish

Résumé

Biomedical data are generated and collected from various sources, including medical imaging, laboratory tests and genome sequencing. Sharing these data for research can help address unmet health needs, contribute to scientific breakthroughs, accelerate the development of more effective treatments and inform public health policy. Due to the potential sensitivity of such data, however, privacy concerns have led to policies that restrict data sharing. In addition, sharing sensitive data requires a secure and robust infrastructure with appropriate storage solutions. Here, we examine and compare the centralized and federated data sharing models through the prism of five large-scale and real-world use cases of strategic significance within the European data sharing landscape: the French Health Data Hub, the BBMRI-ERIC Colorectal Cancer Cohort, the federated European Genome-phenome Archive, the Observational Medical Outcomes Partnership/OHDSI network and the EBRAINS Medical Informatics Platform. Our analysis indicates that centralized models facilitate data linkage, harmonization and interoperability, while federated models facilitate scaling up and legal compliance, as the data typically reside on the data generator's premises, allowing for better control of how data are shared. This comparative study thus offers guidance on the selection of the most appropriate sharing strategy for sensitive datasets and provides key insights for informed decision-making in data sharing efforts.

Identifiants

pubmed: 38836701
pii: 7688102
doi: 10.1093/bib/bbae262
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union's Horizon 2020 Framework Programme
ID : 824087
Organisme : European Union's Horizon Europe Framework Programme
ID : 101057726

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Maria A Rujano (MA)

European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.

Jan-Willem Boiten (JW)

Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.

Christian Ohmann (C)

European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.

Steve Canham (S)

European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.

Sergio Contrino (S)

European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.

Romain David (R)

European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Trône 98/Boîte 4B, 1050, Brussels, Belgium.

Jonathan Ewbank (J)

European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Trône 98/Boîte 4B, 1050, Brussels, Belgium.

Claudia Filippone (C)

European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Trône 98/Boîte 4B, 1050, Brussels, Belgium.

Claire Connellan (C)

European Research Infrastructure on Highly Pathogenic Agents (ERINHA AISBL), rue du Trône 98/Boîte 4B, 1050, Brussels, Belgium.

Ilse Custers (I)

Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.

Rick van Nuland (R)

Foundation Lygature, Jaarbeursplein 6, 3521 AL, Utrecht, The Netherlands.

Michaela Th Mayrhofer (MT)

Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.

Petr Holub (P)

Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.

Eva García Álvarez (EG)

Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC), Neue Stiftingtalstrasse 2/B/6, 8010, Graz, Austria.

Emmanuel Bacry (E)

Health Data Hub (HDH), rue Georges Pitard 9, 75015, Paris, France.

Nigel Hughes (N)

Janssen Research and Development, Antwerpseweg 15, 2340, Beerse, Belgium.

Mallory A Freeberg (MA)

European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute (EBI), Wellcome Genome Campus, CB10 1SD, Hinxton, Cambridgeshire, United Kingdom.

Birgit Schaffhauser (B)

Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 21, 1011, Lausanne, Switzerland.

Harald Wagener (H)

Center for Digital Health, BIH@Charité University Medicine, Anna-Louisa-Karsch-Straße 2, 10178, Berlin, Germany.

Alex Sánchez-Pla (A)

Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Diagonal 643, 08028, Barcelona, Spain.

Guido Bertolini (G)

Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via GB Camozzi 3, 24020, Ranica (Bergamo), Italy.

Maria Panagiotopoulou (M)

European Clinical Research Infrastructure Network (ECRIN), Boulevard Saint Jacques 30, 75014, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH